Hologic Acquires Gynesonics

Hologic Acquires Acessa Health for Approximately $80M

August 25, 2020

Medical Devices

Hologic, Inc. has acquired Acessa Health Inc., a privately held maker of the Acessa ProVu minimally invasive system for treating uterine fibroids, for approximately $80 million in cash plus contingent payments. The tuck-in purchase expands Hologic's GYN surgical portfolio and leverages Hologic's commercial infrastructure to accelerate adoption of Acessa's technology.

Hologic Going Private in $18.3 Billion Deal with Blackstone and TPG (Minority Investment from ADIA and GIC)

October 22, 2025

Medical Devices

Hologic, a women’s health company, entered into a definitive agreement to be acquired for an enterprise value of approximately $18.3 billion by funds managed by Blackstone and TPG. Under the terms, Hologic stockholders will receive $76 per share in cash plus a contingent value right worth up to an additional $3 per share tied to Breast Health revenue milestones.

HistoSonics Announces $2.25B Management-Led Majority Stake Acquisition by Syndicate Including K5 Global, Bezos Expeditions, and Wellington Management

August 10, 2025

Medical Devices

HistoSonics, the developer of the Edison Histotripsy System, announced a management-led majority stake acquisition valuing the company at approximately $2.25 billion. The investment syndicate includes K5 Global, Bezos Expeditions, and Wellington Management, along with other new and existing investors such as Alpha JWC Ventures and Johnson & Johnson’s JJDC.

Organon Acquires Alydia Health

June 16, 2021

Medical Devices

Organon completed its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing postpartum hemorrhage, for total consideration of $240 million (including up to $25 million in contingent milestones). The deal expands Organon’s portfolio into medical devices and leverages its global commercial footprint to broaden access to Alydia’s Jada System for maternal hemorrhage worldwide.

Bioventus Inc. Acquires Misonix, Inc.

July 29, 2021

Medical Devices

Bioventus Inc. entered into a definitive agreement to acquire Misonix, Inc. in a cash-and-stock transaction that values Misonix at approximately $518 million on a fully diluted basis. The deal expands Bioventus' regenerative medicine and surgical solutions portfolio by adding Misonix's minimally invasive ultrasonic technologies and regenerative wound products and is expected to close in the fourth quarter of 2021 subject to customary approvals.

Intelerad Medical Systems Acquires Digisonics, Inc.

December 16, 2020

Healthcare Services

Intelerad Medical Systems, a Montreal-based medical imaging software provider backed by Hg, has acquired Digisonics, Inc., a Houston-based provider of cardiovascular and obstetrics/gynecology information and structured reporting systems. The acquisition will integrate Digisonics' reporting and clinical interpretation capabilities into Intelerad's enterprise imaging platform to eliminate silos, improve physician workflow efficiency, and strengthen Intelerad's hospital and health system offering.